Hybrid Conferencee

International Conference on Oncology and Cancer Therapeutics Development (ICOCTD - 27)

27th - 28th February 2027 | Gdansk, Poland
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Expand the Academic Reach of Your Research - a Q1-ranked and Scopus-indexed journal publication opportunity

Journal consideration and publication are subject to editorial review, peer review and applicable journal policies.

Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Gdansk. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Gdansk event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Gdansk conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Gdansk, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Gdansk."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Cancer Therapeutics

This track will explore the latest innovations in cancer treatment modalities, including chemotherapy, radiotherapy, and targeted therapies. Emphasis will be placed on the integration of novel agents and treatment regimens in clinical practice.

Track 02

Precision Medicine in Oncology

This session will focus on the role of precision medicine in tailoring cancer treatment to individual patient profiles. Discussions will include the use of genomic data and biomarkers to enhance therapeutic efficacy.

Track 03

Immunotherapy: Current Trends and Future Directions

This track will examine the evolving landscape of immunotherapy in oncology, highlighting recent breakthroughs and ongoing clinical trials. Participants will discuss the challenges and opportunities in harnessing the immune system to combat cancer.

Track 04

Translational Oncology: Bridging Bench to Bedside

This session will delve into the critical role of translational research in oncology, focusing on the conversion of laboratory discoveries into clinical applications. Case studies will illustrate successful translation of findings into therapeutic strategies.

Track 05

Cancer Biology and Tumor Microenvironment

This track will investigate the complex interactions between tumor cells and their microenvironment, including stromal cells, immune cells, and extracellular matrix components. Understanding these dynamics is essential for developing effective cancer therapies.

Track 06

Biomarkers in Cancer Diagnosis and Prognosis

This session will highlight the significance of biomarkers in the early detection and prognosis of various cancers. Researchers will present their findings on novel biomarkers and their potential clinical applications.

Track 07

Emerging Targets in Cancer Therapy

This track will focus on the identification and validation of new therapeutic targets in oncology. Discussions will include the implications of targeting specific molecular pathways for cancer treatment.

Track 08

Pediatric Oncology: Unique Challenges and Innovations

This session will address the distinct challenges faced in the treatment of childhood cancers, including the need for tailored therapies. Innovative approaches and recent advancements in pediatric oncology will be discussed.

Track 09

Ethics and Access in Cancer Care

This track will explore the ethical considerations and disparities in access to cancer treatment across different populations. Participants will engage in discussions about equitable healthcare delivery and policy implications.

Track 10

Clinical Trials: Design and Implementation

This session will focus on the methodologies and best practices for designing and conducting clinical trials in oncology. Emphasis will be placed on innovative trial designs and patient recruitment strategies.

Track 11

Integrative Approaches in Cancer Treatment

This track will examine the integration of complementary therapies with conventional cancer treatments. Discussions will highlight the evidence supporting integrative approaches and their impact on patient outcomes.